Citizens Maintains Market Outperform on Hinge Health, Raises Price Target to $96
Benzinga Newsdesk 3 months ago
Analyst RatingsNewsPrice Target
Citizens analyst Aaron Kimson maintains Hinge Health (NYSE:HNGE) with a Market Outperform and raises the price target from $80 to $96.
Citizens analyst Aaron Kimson maintains Hinge Health (NYSE:HNGE) with a Market Outperform and raises the price target from $80 to $96.